Editing Lung (TRPM7)

{{tp|p=35944979|t=2022. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.|pdf=|usr=}}{{35944979}}
{{tp|p=33691194|t=2021. Substantial involvement of TRPM7 inhibition in the therapeutic effect of Ophiocordyceps sinensis on pulmonary hypertension.|pdf=|usr=}}{{33691194}}
{{tp|p=38033335|t=2023. Mechanosensitive channels in lung disease.|pdf=|usr=}}{{38033335}}
{{tp|p=29867539|t=2018. Revisiting the Role of TRP, Orai, and ASIC Channels in the Pulmonary Arterial Response to Hypoxia.|pdf=|usr=}}{{29867539}}
{{tp|p=34349187|t=2021. Transcriptomic profile of cationic channels in human pulmonary arterial hypertension.|pdf=|usr=}}{{34349187}}
{{tp|p=31219801|t=2019. TRPM7 channel inhibition exacerbates pulmonary arterial hypertension through MEK/ERK pathway.|pdf=|usr=}}{{31219801}}
{{tp|p=26874684|t=2016. Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing DeltaF508-CFTR and G551D-CFTR.|pdf=|usr=}}{{26874684}}
{{tp|p=24920677|t=2014. Flow shear stress enhances intracellular Ca2+ signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.|pdf=|usr=}}{{24920677}}
{{tp|p=35053420|t=2022. Endolysosomal Cation Channels and Lung Disease.|pdf=|usr=}}{{35053420}}
{{tp|p=25545236|t=2015. Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels.|pdf=|usr=}}{{25545236}}
{{tp|p=30099957|t=2018. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.|pdf=|usr=}}{{30099957}}
{{tp|p=36034851|t=2022. Efficacy of terpenoids in attenuating pulmonary edema in acute lung injury: A meta-analysis of animal studies.|pdf=|usr=}}{{36034851}}
{{tp|p=30090065|t=2018. Mechanobiological Feedback in Pulmonary Vascular Disease.|pdf=|usr=}}{{30090065}}
{{tp|p=30322215|t=2018. Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?|pdf=|usr=}}{{30322215}}
{{tp|p=36527086|t=2022. Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs.|pdf=|usr=}}{{36527086}}
{{tp|p=35318760|t=2022. Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling.|pdf=|usr=}}{{35318760}}
{{tp|p=33007416|t=2021. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.|pdf=|usr=}}{{33007416}}
{{tp|p=35454073|t=2022. Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.|pdf=|usr=}}{{35454073}}
{{tp|p=34572602|t=2021. Mechanosensitivity in Pulmonary Circulation: Pathophysiological Relevance of Stretch-Activated Channels in Pulmonary Hypertension.|pdf=|usr=}}{{34572602}}
{{tp|p=23733654|t=2011. Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling.|pdf=|usr=}}{{23733654}}
{{tp|p=37254738|t=2023. Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways.|pdf=|usr=}}{{37254738}}
{{tp|p=30125956|t=2019. Pulmonary vascular dysfunction in metabolic syndrome.|pdf=|usr=}}{{30125956}}
{{tp|p=30015354|t=2019. Novel mechanisms regulating endothelial barrier function in the pulmonary microcirculation.|pdf=|usr=}}
{{tp|p=26749564|t=2016. Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability.|pdf=|usr=}}{{26749564}}
{{tp|p=25059284|t=2014. Oxidative stress increases pulmonary vascular permeability in diabetic rats through activation of transient receptor potential melastatin 2 channels.|pdf=|usr=}}{{25059284}}
{{tp|p=22298659|t=2012. Hypoxic pulmonary vasoconstriction.|pdf=|usr=}}{{22298659}}
{{tp|p=25006396|t=2013. Transient receptor potential channels and regulation of lung endothelial permeability.|pdf=|usr=}}{{25006396}}